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Staphylococcus aureus, an important pathogen of humans and other warm-blooded animals, is also capable
of killing the nematode Caenorhabditis elegans. Here, we show that C. elegans organisms that are fed S. aureus
die over the course of several days in a process that is correlated with the accumulation of bacteria within the
nematode digestive tract. Several S. aureus virulence determinants known or speculated to be important in
mammalian pathogenesis, including the quorum-sensing global virulence regulatory system agr and the global
virulence regulator sarA, the alternative sigma factor B, alpha-hemolysin, and V8 serine protease, are
required for full pathogenicity in nematodes. In addition, several defined C. elegans mutants were examined for
susceptibility to S. aureus infection. Enhanced susceptibility to S. aureus killing was observed with loss-of-
function mutations in the C. elegans genes esp-2/sek-1 and esp-8/nsy-1, which encode components of a conserved
p38 MAP kinase signaling pathway involved in nematode defense against multiple pathogens. These results
suggest that key aspects of S. aureus pathogenesis have been conserved, irrespective of the host, and that
specific C. elegans host factors can alter susceptibility to this gram-positive human pathogen.
The gram-positive bacterium Staphylococcus aureus is one of
the leading causes of both community-acquired and hospital-
acquired infections worldwide (30, 82) and is also an econom-
ically important cause of bovine and ovine mastitis (3, 80). S.
aureus is a remarkably versatile pathogen in humans, capable
of causing diseases as diverse as superficial skin infections and
soft tissue abscesses and life-threatening infections, such as
sepsis, endocarditis, pneumonia, and toxic shock syndrome
(52). Treatment of S. aureus infections has become compli-
cated by the emergence of widespread antimicrobial resis-
tance. Isolates resistant to methicillin have steadily increased
over the last 3 decades and now cause one-half of all nosoco-
mial S. aureus infections in the United States (4, 30). Most
methicillin-resistant S. aureus isolates are resistant to multiple
antibiotics (73), and clinical S. aureus isolates with reduced
susceptibility (39, 78) and full resistance (5) to vancomycin
have been reported.
The ability of S. aureus to cause a wide spectrum of disease
has been attributed to its ability to produce a broad array of
pathogenicity factors (6). These factors can be subdivided into
three general groups: cell-associated products, secreted exo-
proteins, and regulatory loci. Cell-associated products, includ-
ing adhesins of the MSCRAMM (microbial surface compo-
nents recognizing adhesive matrix molecules) family and
capsular polysaccharide, facilitate binding to host tissue and
help resist host immune responses. Secreted exoproteins, such
as cytolysins (e.g., alpha-hemolysin) and extracellular pro-
teases (e.g., V8 protease), are thought to combat host defenses
and facilitate tissue invasion and nutrient acquisition (62). Ex-
pression of these pathogenicity factors is intricately regulated
by a large number of interacting regulatory genes (agr, sarA,
sarH1 [sarS], saeR-saeS, rot, srrA-srrB, and arlS-arlR) in re-
sponse to a variety of environmental conditions (bacterial pop-
ulation density, osmolarity, catabolite concentration, oxygen
tension, and pH) (62). The most extensively studied regulators
are the global virulence regulatory loci agr and sarA.
The agr (for accessory gene regulator) locus—composed of
two divergent transcripts, RNAII (encoding agrA, agrB, agrC,
and agrD) and RNAIII—acts to suppress production of cell-
associated products while enhancing secreted exoprotein pro-
duction in response to high bacterial population density in
vitro. AgrA and AgrC constitute a two-component histidine
kinase-response regulator pair that responds to the extracellu-
lar accumulation of a thiolactone-modified octapeptide pher-
omone, generated by AgrD and AgrB. This autoinducing quo-
rum-sensing circuit induces the expression of RNAIII, a
regulatory RNA molecule that acts as the effector molecule of
the agr system. agr mutants are attenuated in several animal
models of S. aureus disease, including endocarditis, osteomy-
elitis, septic arthritis, renal and soft tissue abscesses, and en-
dophthalmitis, confirming the importance of coordinate viru-
lence gene regulation in vivo (2, 12, 18, 21, 27).
The sarA (for staphylococcal accessory regulator) locus en-
codes a 14.5-kDa transcriptional regulator (SarA) that is also
involved in cell-associated and secreted protein production.
SarA binds to agr promoter elements and is required for full
activation of the agr locus (20, 25, 71). In addition, SarA can
act independently of RNAIII to directly activate or repress
virulence gene expression (9, 10, 17, 51, 84). For example,
RNAIII induces exoprotease production, whereas SarA para-
doxically represses exoprotease production (9, 17, 22). Thus,
SarA has both agr-dependent and agr-independent effects on
virulence gene expression. Like agr, the sarA locus has been
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shown to be important in a number of animal models of S.
aureus pathogenesis, including endocarditis, septic arthritis,
and endophthalmitis (13, 21, 61). Compared to single-locus
disruptions, inactivation of both sarA and agr results in more
marked attenuation in vivo (13, 21, 45).
Previously, our laboratories reported the development of a
novel host-pathogen model system for gram-positive human
pathogens using the nematode Caenorhabditis elegans as a
model genetic host. We have shown that Enterococcus faecalis
kills adult nematodes over the course of several days in a
process that has the characteristics of a persistent infection.
Several E. faecalis virulence-related factors, including cytoly-
sin, the extracellular proteases gelatinase and serine protease,
and the two-component quorum-sensing system fsr, are impor-
tant for pathogenicity in both C. elegans and mammalian mod-
els of enterococcal infection (36, 59, 69, 76, 77). A p38-like
mitogen-activated protein (MAP) kinase signaling pathway in
C. elegans that is important in defense against E. faecalis killing
has also been recently identified. Two strains with mutations of
this pathway, esp-2 and esp-8 (esp for enhanced susceptibility to
pathogen), were identified in a genetic screen as being hyper-
susceptible to killing by the gram-negative human pathogen
Pseudomonas aeruginosa (46).
In a previous study of the C. elegans-E. faecalis model, it was
briefly noted that a clinical isolate of S. aureus was capable of
killing C. elegans (36). In the present study, we examined in
detail the antagonistic interaction between S. aureus and C.
elegans. C. elegans was killed by a variety of S. aureus strains,
and this killing was associated with the accumulation of live
bacteria within the nematode alimentary tract. Several S. au-
reus virulence determinants, known or speculated to be impor-
tant in mammalian pathogenesis, were required for full viru-
lence in nematodes. In turn, C. elegans esp-2 and esp-8 mutants
were also more susceptible to S. aureus killing. Taken together,
these results demonstrate that C. elegans can be used as a
model host to explore S. aureus pathogenic mechanisms and
the interaction with host innate immune defenses.
(This work was presented, in part, at the 102nd General
Meeting of the American Society for Microbiology, Salt Lake
City, Utah, in May 2002.)
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used in this
study are listed in Table 1. All strains were maintained at 70°C in tryptic soy
(TS), brain-heart infusion (BHI), or Luria-Bertani medium (Difco Laboratories,
Detroit, Mich.) containing 15% glycerol. S. aureus strains were grown with
TABLE 1. Strains and plasmids used
Strain or plasmid Relevant genotype and/or phenotypea Reference and/or source
S. aureus
A002 Clinical S. aureus isolate MGHb; this study
A003 Clinical S. aureus isolate 36
A091 Clinical S. aureus isolate MGH; this study
NCTC 8325 Wild-type strain; rsbU mutant 41; The Staphylococcal Genetic
Stock Center; J. J. Iandolo
NCTC 8325-4 Prophage-cured derivative of NCTC 8325; rsbU mutant 63 S. J. Foster
RN6390 Prophage-cured derivative of NCTC 8325 68; A. L. Cheung
RN6390B RN6390 reisolated in the Novick laboratory with stable
alpha-hemolysin production
64; M. J. McGavin
COL Wild-type Mcr strain; mec 75; G. B. Pier
Newman ATCC 25904; high level of clumping factor; B 32; M. Bischoff
Reynolds Wild-type strain; type 5 capsular polysaccharide 49; J. C. Lee
RN6911 RN6390 agr::tetM agr sarA Tcr 47; A. L. Cheung
ALC488 RN6390 sarA::ermC agr sarA Emr 19; A. L. Cheung
ALC837 RN6390 hla::ermC Hla Emr 45; A. L. Cheung
ALC842 RN6390 agr::tetM sarA::ermC agr sarA Tcr Emr 19; A. L. Cheung
SP6391 RN6390B sspA::ermAB SspA Emr 72; M. J. McGavin
IK194 Newman rsbUVW sigB::ermB B Emr 8; M. Bischoff
ALC1435 RN6390(pALC1420) sarA P1 promoter::gfpuv 23; A. L. Cheung
SH1000 NCTC 8325-4 rsbU 40; S. J. Foster
E. coli
OP50 Uracil auxotrophy 15; laboratory collection
DH5(pSMC2) DH5 containing a stable plasmid which constitutively
expresses a bright mutant of A. victoria GFP; Apr
11
E. faecium
E007 Clinical E. faecium isolate 36
B. subtilis
PY79 Laboratory strain 85
C. elegans
Bristol N2 Wild-type strain Laboratory strain
AU1 esp-2(ag1) 46; D. H. Kim
AU3 esp-8(ag3) 46; D. H. Kim
BA1 fer-1(hc1) Laboratory strain
a Abbreviations: Mc, methicillin; Tc, tetracycline; Em, erythromycin; Ap, ampicillin; Hla, alpha-hemolysin; SspA, V8 protease.
b MGH, Massachusetts General Hospital.
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aeration at 37°C in TS broth that was supplemented with the following antibiotics
when appropriate: nalidixic acid, 5 g/ml; erythromycin, 5 g/ml; and tetracy-
cline, 10 g/ml. Enterococcus faecium E007, a clinical strain that has relatively
little nematocidal activity (36), was grown in BHI broth (Difco). Bacillus subtilis
PY79, a laboratory strain that also has minimal nematocidal activity (36), was
grown in TS broth. Escherichia coli strains were grown in Luria-Bertani broth
supplemented when appropriate with ampicillin (50 g/ml). Solid medium was
prepared by the addition of 15 g of Bacto Agar (Difco) per liter.
C. elegans strains are listed in Table 1. The nematodes were maintained at
15°C on nematode growth medium plates spread with Escherichia coli strain
OP50 as a food source (15, 50). The nematodes were manipulated using estab-
lished techniques (50).
Nematode-killing assay. Unless otherwise indicated, S. aureus, E. faecium, and
B. subtilis assay plates were prepared as follows. S. aureus strains were grown
overnight at 37°C in TS broth supplemented with selective antibiotics as needed.
A 1:10 dilution of the saturated culture was made in TS broth, and 10 l of the
diluted culture was spread on 3.5-cm-diameter plates containing TS agar sup-
plemented with 5 g of nalidixic acid/ml. B. subtilis PY79 was grown overnight at
37°C in TS broth, and 10-l aliquots of the saturated culture were spread on
3.5-cm-diameter plates containing TS agar. E. faecium E007 was grown overnight
at 37°C in BHI broth, and 10-l aliquots of the saturated culture were spread on
3.5-cm-diameter plates containing TS agar supplemented with 5 g of nalidixic
acid/ml. The plates were incubated at 37°C for 4 to 6 h and then allowed to
equilibrate to room temperature for 30 to 60 min before being seeded with
worms.
In each assay, 30 to 40 L4-stage nematodes were added per plate, and each
assay was carried out in triplicate. The plates were incubated at 25°C and scored
for live and dead worms at least every 24 h. A worm was considered dead when
it failed to respond to plate tapping or gentle touch with a platinum wire. Worms
that died as a result of getting stuck to the wall of the plate were censored from
the analysis.
C. elegans pulse-chase experiments. Sixty to 70 L4-stage nematodes were
placed on S. aureus strain NCTC 8325 (hereafter referred to as 8325) lawns
grown on TS agar plates, as described above and allowed to feed. After 14, 18,
or 24 h, one-half of the total number (between 30 and 35 per plate) were
transferred to TS agar plates containing E. faecium E007; the remainder were
transferred to TS agar plates spread with 8325. E007 was used as an innocuous
food source, because it specifically kills eggs and young hatchlings while allowing
normal adult longevity, thus making it easier to keep track of the original adult
nematodes through the course of the experiment.
ALC1435 contains the plasmid pALC1420, a recombinant vector derivative of
the E. coli-S. aureus shuttle plasmid pSK236 containing a sarA P1 promoter::gfpuv
transcriptional fusion (23). The worms were allowed to feed on ALC1435 on TS
agar for 24 h and then were transferred to TS agar plates spread with lawns of
8325. After feeding on the 8325 lawn for defined periods, the worms were
examined by confocal fluorescence microscopy.
Microscopy. The nematodes were examined by differential interference con-
trast microscopy with Nomarski optics using a Zeiss Axioplan2 microscope and
by confocal fluorescence microscopy using a Leica TCS NT confocal microscope
with spectrophotometric detection by established methodologies (79).
Statistical analysis. For each killing assay, nematode survival was calculated
by the Kaplan-Meier method, and survival differences were tested for signifi-
cance by use of the log rank test (GraphPad Prism, version 3.0; GraphPad
Software, Inc., San Diego, Calif., 1999).
RESULTS
S. aureus kills C. elegans. It was previously shown that the S.
aureus clinical isolate A003 killed C. elegans over the course of
several days (36). To determine whether the ability to kill C.
elegans is a common property of S. aureus strains, we tested the
abilities of 23 independent clinical S. aureus isolates to kill
nematodes. A majority (70%) killed 70% of the nematodes
during the course of a standard experiment (5 days). Repre-
sentative data for three clinical isolates, two that demonstrated
significant killing activity (isolates A003 and A091) and one
that had marginal killing activity (isolate A002), are shown in
Fig. 1A.
We also tested the abilities of several well-characterized S.
aureus laboratory strains to kill C. elegans. As shown in Fig. 1B,
all of the laboratory strains tested exhibited a high level of
nematocidal activity. 8325 is a well-studied strain used by Pat-
tee and colleagues to generate a physical and genetic map of
S. aureus (41). COL is a prototypical methicillin-resistant S.
aureus strain (75). 8325 and COL are being fully sequenced
at the University of Oklahoma Genome Center (http://www
.genome.ou.edu/staph.html) and The Institute for Genomic
Research (http://www.tigr.org), respectively, and both strains
have been used in numerous animal models of S. aureus infec-
tion. RN6390 is a derivative of 8325 that has been cured of
prophages and that exhibits stable alpha-hemolysin production
(68). Newman (ATCC 25904) is a clinical isolate that produces
a high level of clumping factor (32). Reynolds is a wild-type
isolate with type 5 capsular polysaccharide used in experimen-
tal vaccine studies (49).
Nematodes progress through four larval stages (called L1 to
L4) before maturing into egg-laying adults. All of these devel-
opmental stages were killed by S. aureus. Most S. aureus
FIG. 1. C. elegans killing by S. aureus. (A) Kaplan-Meier survival plots of worms fed S. aureus clinical isolates A002 (squares) (n  78), A003
(circles) (n 88), and A091 (triangles) (n 91) and B. subtilis strain PY79 (diamonds) (n 59; negative control). (B) Kaplan-Meier survival plots
of worms fed S. aureus strains RN6390 (circles) (n  85), Newman (squares) (n  87), COL (triangles) (n  92), Reynolds (solid diamonds) (n
 101) and B. subtilis strain PY79 (open diamonds) (n  59; negative control).
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strains, including those clinical isolates that killed late larval
(L4-stage) and adult worms poorly, efficiently killed the early
larval stages so that no nematode population growth occurred
under standard assay conditions. As has been reported for P.
aeruginosa PA14 (55, 81), both the medium on which the bac-
terial lawn was grown and the developmental stage of the
worms played important roles in determining the rate of kill-
ing. In the case of S. aureus killing, adult worms were moder-
ately more susceptible than L4-stage worms, and the nema-
todes survived slightly longer on BHI agar than on TS agar
(data not shown). No killing was observed when the nematodes
were fed either heat- or antibiotic-killed S. aureus (data not
shown), suggesting that killing requires the presence of live
bacteria.
Killing is correlated with colonization of the nematode in-
testine by S. aureus. When the worms were feeding on S.
aureus, nematode locomotion, pharyngeal pumping, and for-
aging appeared normal for the first 16 to 20 h. Over the next 24
to 48 h, all of these activities progressively decreased until the
worms became immobile and died. Many dead nematodes lost
all apparent cellular architecture and appeared as “ghosts” in
the bacterial lawn. We have observed this same phenotype
after nematode feeding on E. faecalis, and O’Quinn and col-
leagues reported that nematodes that died while feeding on
Burkholderia pseudomallei also appear as ghosts in the bacte-
rial lawn (65). Moreover, we occasionally observed the so-
called “bag of worms” phenotype, in which the eggs of a gravid
hermaphrodite hatched internally and the resulting larvae con-
sumed the parent (58). Bagging has been observed when nem-
atodes feed on other pathogens and is particularly prominent
with E. faecalis (36). Although it is not known why bagging is
prevalent when nematodes feed on bacterial pathogens, one
possibility is that infected worms may become too weak to lay
eggs normally. Matricide is not the sole mechanism of killing,
however, since males and the sterile mutant fer-1 were also
killed by S. aureus (data not shown).
Worms fed S. aureus accumulated bacteria within their di-
gestive tracts. Examination of the worms by Nomarski differ-
ential interference contrast microscopy showed significant dis-
tention of the intestinal lumen with large numbers of intact
bacteria. In contrast, worms fed E. coli or B. subtilis had slen-
der intestinal lumina with no visible intact bacteria (data not
shown). To confirm that distention is due to the accumulation
and/or proliferation of live S. aureus, we examined worms fed
on lawns of strain ALC1435, a RN6390 transformant contain-
ing a shuttle vector with a sarA P1 promoter::gfpuv transcrip-
tional fusion, which expresses Aequorea victoria green fluores-
cent protein (GFP) constitutively. After 24 h of nematode
feeding on ALC1435, confocal fluorescence microscopy re-
vealed innumerable fluorescent cocci throughout the dis-
tended lumens of the worm intestines (Fig. 2A). In contrast,
nematodes fed GFP-expressing E. coli DH5 had only a small
number of intact fluorescent bacilli in the proximal intestine
(Fig. 2B).
To further investigate the mechanisms of S. aureus killing of
C. elegans, we tested the ability of worms to be rescued from S.
aureus exposure. L4-stage worms were allowed to feed on
lawns of 8325 for various lengths of time and then were trans-
ferred to either another plate of 8325 or a plate with the
nonpathogenic bacterium E. faecium E007. To limit the ability
of inadvertently transferred 8325 to grow on the E007 plate, we
added gentamicin (25 g/ml) to the media, which selectively
kills 8325. As shown in Fig. 3A, transfer to the E. faecium plate
rescued worms from S. aureus exposure until that exposure was
FIG. 2. Distention of the C. elegans digestive tract with S. aureus but not E. coli. Shown are confocal fluorescence photomicrographs of the
terminal bulb and anterior intestinal tracts of nematodes after feeding for 24 h on lawns of S. aureus RN6390/gfp (ALC1435) (A) or E. coli
DH5/gfp (B). (A) The nematode intestinal lumen, from the terminal bulb (arrow) to the anus (arrowhead) was distended with GFP-expressing
cocci after the worm was fed RN6390/gfp. (B) In contrast, only a few GFP-expressing bacilli (arrows) were observed in the nondistended intestinal
tracts of worms feeding on DH5/gfp. Magnification, 	63.
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18 h or longer. Worms transferred at 8 h of exposure or earlier
had normal life spans (data not shown). Interestingly, as de-
scribed above, most worms appeared to feed and behave nor-
mally for the first 16 to 20 h of feeding. Similar results were
obtained when worms were transferred from lawns of 8325 to
E007 plates grown without gentamicin, suggesting that rescue
was not simply a result of antibiotic treatment of S. aureus
within the nematode intestinal tract. These data suggest that
worms are unable to recover from the deadly effect of exposure
to S. aureus once they have been in contact with the bacteria
for a sufficient length of time (8 h for strain 8325). These data
also suggest that S. aureus can be cleared from the nematode
gut once the worms are transferred to a new food source. In
contrast, E. faecalis persistently colonizes and proliferates in
the nematode gut, even after transfer to an innocuous food
source (36).
To explore the question of persistent colonization further,
we examined worms that were first allowed to feed on
ALC1435 for 24 h and were then transferred to plates of
nonfluorescent RN6390. After the worms fed on RN6390, the
FIG. 3. S. aureus does not persistently colonize the digestive tract of C. elegans. (A) C. elegans pulse-chase experiment (see Materials and
Methods) showing nematode survival after transfer from S. aureus strain 8325 to either 8325 (solid symbols) or E. faecium E007 (open symbols):
the worms were transferred after feeding for 14 (squares), 18 (triangles), and 24 (diamonds) h. (B) Confocal fluorescence photomicrograph of a
nematode shifted to 8325 after feeding for 24 h on S. aureus RN6390/gfp. The image was obtained 45 min after transfer of the worm. Densely
packed GFP-expressing cocci are visible in the midportion of the intestinal tract of the worm (thick arrow), whereas a few dozen GFP-expressing
cocci are identifiable more proximally (thin arrows) in the distended anterior intestinal lumen, distal to the terminal bulb. Weak autofluorescence
(red channel) of nematode intestinal cells is also visible (arrowhead). Magnification, 	63.
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bolus of fluorescent S. aureus moved down the intestinal lumen
(Fig. 3B). After 2 h, no fluorescence could be detected in the
nematode alimentary tract (data not shown).
Virulence determinants important for S. aureus pathogene-
sis in mammals are also involved in killing C. elegans. To test
the hypothesis that S. aureus utilizes the same virulence strat-
egies to infect both C. elegans and mammalian hosts, we eval-
uated in the nematode model system sets of isogenic S. aureus
strains carrying mutations in virulence determinants important
for mammalian infection. First, we tested the roles of the S.
aureus global virulence regulators agr and sarA in nematocidal
activity. Compared to the parental strain RN6390, C. elegans
killing was highly attenuated while feeding on lawns of the agr
mutant RN6911 and was moderately attenuated on lawns of
the sarA mutant ALC488 and the agr-sarA double mutant
ALC842 (Fig. 4A). There was no significant difference in kill-
ing between ALC488 and ALC842.
Next, we examined the role in C. elegans killing of S. aureus
alpha-hemolysin, the production of which is positively regu-
lated by both agr and sarA (dependent on and independent of
agr) (17, 21). Alpha-hemolysin, encoded by hla, is a potent
cytolytic pore-forming toxin that has been shown to be an
important virulence factor in a number of mammalian models
of S. aureus infection (14, 16, 45, 57, 67). We compared the
survival of nematodes feeding on the hla mutant ALC837 to
those feeding on the parental strain RN6390. As shown in Fig.
4B, ALC837 was significantly attenuated in worm killing com-
pared to RN6390, demonstrating that alpha-hemolysin is im-
portant for S. aureus virulence in C. elegans as well as verte-
brate hosts.
Considering that virulence gene regulation by sarA acts, in
part, through agr, we were interested in further investigating
the difference in phenotype between agr (highly attenuated)
and sarA (moderately attenuated) mutants in C. elegans. We
speculated that the difference in the agr and sarA mutant
strains may be reflective of agr-independent sarA virulence
gene regulation. To test this hypothesis, we evaluated the role
of V8 protease, encoded by sspA, in C. elegans killing, since its
production is contrarily regulated by the agr (a protease acti-
vator) and sarA (a protease repressor) loci (9, 17, 43). Re-
cently, the importance of V8 protease to in vivo survival and
virulence in three different animal models of infection was
demonstrated by signature-tagged mutagenesis (27). The
nematocidal activity of strain SP6391, which carries a nonpolar
mutation in the V8 protease gene sspA, was examined. SP6391
was significantly attenuated in C. elegans killing compared to
the parental strain RN6390B (Fig. 4B). Thus, increased pro-
duction of certain virulence-related products, like V8 protease,
in the sarA mutant may partially counterbalance the reduced
production of other virulence factors, like alpha-hemolysin,
thereby explaining the moderately attenuated phenotype of the
sarA mutant.
Since the agr system acts to induce exoprotein production
(including alpha-hemolysin and V8 protease) at high cell den-
sity, post-exponential-phase cells would be predicted to be
more virulent than exponential-phase cells in nematode killing.
To test this hypothesis, we compared C. elegans survival on
lawns of S. aureus grown for 24 h (thick-lawn assay) with those
grown for 4 h (standard assay). After 24 h of feeding, nema-
tode survival was moderately shorter in the thick-lawn assay
than in the standard assay for most strains tested, in agreement
with this hypothesis. However, final nematode mortality was
greater in the standard assay than in the thick-lawn assay for
many strains (data not shown).
The role of the alternative sigma factor B in the response of
S. aureus to stress and its potential role in virulence has been
the focus of several recent studies (37, 40, 48, 60). Although B
has been shown to positively regulate sarA expression, heat
tolerance, hydrogen peroxide resistance, and biofilm formation
in response to environmental stress (7, 29, 38, 70), a direct role
for B in virulence has not been demonstrated to date in vivo
(60). Importantly, S. aureus strain 8325, used in most of the C.
elegans-killing assays described above, is a natural B mutant,
by virtue of an 11-bp deletion in the sigB activator, rsbU,
suggesting that B may not play a significant role in C. elegans
killing. To further investigate the role, if any, of B in C.
elegans killing, we tested two different sigB deletion mutants
paired with their parental strains, as well as SH1000, a rsbU
derivative of strain NCTC 8325-4. In all cases, the strains
expressing B were modestly (but significantly) more virulent
than the isogenic B-deficient strains. An example is shown in
Fig. 4C, comparing SH1000 with its parent, NCTC 8325-4. To
our knowledge, this is the first in vivo demonstration of a role
for B in virulence.
Mutants with mutations of the nematode innate immune
system are hypersusceptible to S. aureus killing. Two C. el-
egans mutants that exhibit enhanced susceptibility to patho-
gens, esp-2 and esp-8, have recently been characterized (46).
These mutants have normal life spans when fed E. coli, the
normal nematode food source, but are markedly more suscep-
tible to P. aeruginosa-mediated killing than wild-type worms.
esp-2 corresponds to the C. elegans sek-1 gene, which encodes
a MAP kinase kinase, and esp-8 corresponds to the C. elegans
nsy-1 gene, which encodes an upstream MAP kinase kinase
kinase. SEK-1 is homologous to the MKK3/6 and MKK4 fam-
ily of mammalian MAPKKs, while NSY-1 is a homologue of
the mammalian ASK-1 MAPKKK. SEK-1/ESP-2 and NSY-1/
ESP-8 function in a MAP kinase signaling pathway that acti-
vates the C. elegans p38 MAP kinase ortholog, PMK-1, sug-
gesting that this pathway may be an ancient conserved
component of the nematode immune response to pathogen
attack (46). As shown in Fig. 5, esp-2 and esp-8 mutants of C.
elegans were also more susceptible to killing by the wild-type S.
aureus strain 8325.
DISCUSSION
There is growing interest in using nonvertebrate, genetically
tractable organisms as model hosts to investigate virulence
mechanisms of and defense responses against human patho-
gens (33, 34, 54, 83). In this study, we report the development
of an S. aureus-C. elegans pathogenicity model system that
demonstrates significant parallels to S. aureus infections in
vertebrates at the molecular level.
A broad spectrum of clinical and laboratory S. aureus strains
kill nematodes when substituted for E. coli as nutriment. In-
terestingly, different S. aureus strains killed nematodes with
various efficiencies. Strain-specific differences in C. elegans kill-
ing have been observed as well for P. aeruginosa (28, 55, 81), E.
faecalis (36), Salmonella enterica (1), and B. pseudomallei (35,
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65), suggesting that different strains encode or express different
complements of virulence-related factors (26). Worm death
occurred after feeding on S. aureus for 48 to 72 h for most
strains tested, which is faster than killing observed with E.
faecalis but not as fast as that with Streptococcus pneumoniae
(36). Like E. faecalis, P. aeruginosa, and S. enterica, killing by S.
aureus was associated with the accumulation of live bacteria
within the nematode alimentary tract. Moving nematodes to a
benign food source cleared intestinal colonization with S. au-
reus. P. aeruginosa also accumulates but does not persist in the
nematode intestine, whereas E. faecalis and S. enterica accu-
mulate, persist, and proliferate in the nematode intestine (1,
36, 81). How some bacteria persist in the nematode digestive
tract is not known.
Recently, Jansen et al. reported that killing of C. elegans by
Streptococcus pyogenes and probably S. pneumoniae is medi-
ated by hydrogen peroxide (42). Killing by these organisms
occurs within a matter of hours and is not associated with the
accumulation of bacteria within the nematode alimentary tract.
In addition, the authors reported that S. aureus did not kill C.
elegans in their assays, in contrast to our finding that most
strains have potent nematocidal activity. Perhaps the strain
used in their assays, SAI, H Mi1, has little intrinsic virulence
toward C. elegans, as we have found with a subset of clinical
isolates. Alternatively, the lack of killing may be a reflection of
the different assay conditions used. For example, S. aureus was
cultured in Todd-Hewitt medium supplemented with 0.5%
yeast extract (THY medium) in the assays carried out by
Jansen et al., whereas our assays were all performed on TS
agar. We found that S. aureus grown on TS agar was more
FIG. 4. Mammalian virulence factors enhance S. aureus killing of
C. elegans. (A) Kaplan-Meier survival plots of worms fed S. aureus
strains RN6390 (wild type; n  103) (solid circles), RN6911 (agr
mutant; n 105) (squares), ALC488 (sarA mutant; n 92) (triangles),
ALC842 (agr sarA double mutant; n  113) (diamonds), and B. subtilis
strain PY79 (negative control; n  61) (open circles). Pairwise com-
parisons (log rank test) by strain were as follows: RN6390 versus
RN6911, P 
 0.0001; RN6390 versus ALC488, P 
 0.0001; RN6390
versus ALC842, P 
 0.0001; ALC488 versus ALC842, P  0.6.
(B) Kaplan-Meier survival plots of worms fed S. aureus strains RN6390
(wild type; n  85) (solid circles), ALC837 (RN6390 hla mutant; n 
103) (open circles), RN6390B (wild type; n  95) (solid squares), and
SP6391 (RN6390B sspA mutant; n  98) (open squares). Pairwise
FIG. 5. C. elegans mutants with enhanced susceptibility to S. aureus
killing. Shown are Kaplan-Meier survival plots of wild-type N2 C.
elegans (n  102) (circles), esp-2(ag1) mutant worms (n  91)
(squares), and esp-8(ag3) mutant worms (n  84) (triangles) fed S.
aureus strain 8325. Pairwise comparisons (log rank test) by worm strain
were as follows: N2 versus esp-2(ag1), P 
 0.0001; N2 versus esp-
8(ag3), P 
 0.0001.
comparisons (log rank test) by strain were as follows: RN6390 versus
ALC837, P 
 0.0001; RN6390B versus SP6391, P 
 0.0001.
(C) Kaplan-Meier survival plots of worms fed S. aureus strains NCTC
8325-4 (wild type; n  101) (solid circles) and SH1000 (NCTC 8325-4
rsbU; n  114) (open circles). Pairwise comparison (log-rank test) by
strain: NCTC 8325-4 versus SH1000, P 
 0.0001.
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pathogenic than that grown on BHI agar. Similarly, C. elegans
killing by P. aeruginosa is dependent on the media used (55,
81). The virulence to C. elegans of the S. aureus strains evalu-
ated in this report, if grown in THY medium, is not known.
The S. aureus global virulence regulators agr and, to a lesser
extent, sarA were required for full nematocidal activity; inter-
estingly, an agr-sarA double mutant was no more attenuated
than a sarA mutant itself. A homologue of the agr locus, the E.
faecalis fsr virulence regulator, controls the production of two
extracellular proteases, gelatinase and serine protease, which
are also required for full virulence in both C. elegans and mice
(69, 76). Production of extracellular proteases in S. aureus is
similarly activated by the agr locus but is repressed by the sarA
locus (9, 17, 43). Like E. faecalis serine protease, we found that
S. aureus V8 protease was important in C. elegans killing. In
addition to V8 protease, both agr and sarA regulate the pro-
duction of other secreted products, such as alpha-hemolysin
(17, 24, 47), and we found that alpha-hemolysin was also re-
quired for C. elegans killing. Differences in C. elegans killing
between agr and sarA mutants, therefore, may be due, at least
in part, to differences in regulation of virulence gene expres-
sion in these strains (31). The fact that the agr-sarA double
mutant was no more attenuated in C. elegans killing than the
sarA single mutant (and less attenuated that the agr single
mutant) may reflect the complex interplay of virulence gene
expression directed by RNAIII and SarA in S. aureus.
The alternative sigma factor B controls the general stress
response and influences the production of many virulence-
associated products in S. aureus. Inactivation of B had a small
but demonstrable negative effect on virulence in C. elegans but
not in four previously reported animal models (40, 60). The
effect of B on virulence in C. elegans but not in rodents may
reflect a fundamental difference between nematodes and high-
er-order hosts. Alternatively, the ability to assay the survival of
hundreds of worms in each experiment may allow the C. el-
egans model to detect small differences in S. aureus in vivo
fitness not easily observed in vertebrate hosts. Interestingly,
B-positive strains have decreased production of V8 serine
protease and alpha-hemolysin, possibly due to reduced levels
of RNAIII (8, 38, 40, 66). Why B-positive strains were mea-
surably more virulent than isogenic B-deficient strains in nem-
atodes, despite having reduced levels of SspA and Hla, is not
known. The most straightforward explanation is that altered
levels of other B-dependent gene products compensate for
the reduced production of these extracellular proteins impor-
tant for nematode infection.
C. elegans esp-2 and esp-8 mutants exhibited increased sus-
ceptibility to S. aureus infection, demonstrating that a con-
served p38 MAP kinase signaling pathway is important in in-
nate immunity against S. aureus, as previously shown for P.
aeruginosa. In human neutrophils, phagocytosis of S. aureus
activates p38 MAP kinase and induces apoptosis (53, 56). In-
hibition of p38 MAP kinase along with p44/42 MAP kinase
partially inhibits neutrophil destruction of S. aureus in vitro
(74). While p38 MAP kinase appears to be important in nem-
atode defense, the effectors of the innate immune response to
S. aureus infection are not known. Recently, Kato and col-
leagues have identified a C. elegans antimicrobial peptide,
called ABF-2, which is primarily produced in the worm phar-
ynx and appears to be secreted into the pharyngeal lumen.
Recombinant ABF-2 was shown to have broad antimicrobial
activities against gram-positive bacteria, gram-negative bacte-
ria, and yeast. Of the organisms tested, ABF-2 was most active
against S. aureus, with a 50% microbicidal concentration of
0.005 M (44). The role of ABF-2 in nematode defense against
S. aureus in vivo is under investigation.
The experiments presented here demonstrate that S. aureus
infects C. elegans, ultimately leading to worm death, and that
key aspects of S. aureus pathogenesis and interaction with the
innate immune system have been mechanistically conserved
from nematodes through vertebrates. Based on our prior ex-
perience with similar pathogen-nematode systems, we predict
that C. elegans will be a useful model for the identification of
novel staphylococcal genes important in mammalian pathogen-
esis and for continued exploration of host innate immune de-
fense systems.
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